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Abstract The glucocorticoid receptor (GR) and myocyte
enhancer factor 2 (MEF2) are transcription factors involved
in neuronal plasticity. c-JUN, a target gene of GR and
MEF2, plays a role in regulating both synaptic strength
and synapse number. The aim of this study was to investi-
gate the nature of this dual regulation of c-JUN by GR and
MEF2 in a neuronal context. First, we showed that GR
mediates the dexamethasone-induced suppression of c-
JUN mRNA expression. Next, we observed that GR activa-
tion resulted in an increase in phosphorylation of MEF2, a
post-translational modification known to change MEF2
from a transcriptional enhancer to a repressor. In addition,
we observed an enhanced binding of MEF2 to genomic sites
directly upstream of the c-JUN gene upon GR activation.
Finally, in primary hippocampal neuronal cultures, knock-
down of MEF2 not only reduced c-JUN expression levels
but abolished GR regulation of c-JUN expression. This
suggests that MEF2 is necessary for GR regulation of
c-JUN. In conclusion, for the first time, we show that
activated GR requires MEF2 to regulate c-JUN. At the
same time, GR influences MEF2 activity and DNA binding.
These results give novel insight into the molecular interplay of
GR and MEF2 in the control of genes important for neuronal
plasticity.
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Abbreviations





GRE Glucocorticoid response element
HPA-axis Hypothalamic–pituitary–adrenal axis
IEG Immediate-early gene
MBS MEF2 binding site
MEF2 Myocyte enhancer factor 2
PC-12 Pheochromocytoma cells
Introduction
Neuronal plasticity, a change in the structure, function, and
organization of neurons in response to environmental stim-
uli, underlies many key processes such as learning and
memory, adaptation, and behavioral sensitization. Changes
in gene expression, governed by key transcription factors,
such as the glucocorticoid receptor (GR) and myocyte en-
hancer factor 2 (MEF2), underlie neuroplasticity. GR is
activated by glucocorticoid stress hormones, released by
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the HPA-axis in response to stress. Upon activation, GR acts
as a ligand-activated transcription factor to influence expres-
sion of a wide variety of genes, including genes involved in
neuronal plasticity (Datson et al. 2008). MEF2 comprises a
family of four members, MEF2a–d, showing distinct but
partly overlapping expression patterns and is activated by
neuronal activity. Upon activation, MEF2 regulates the ex-
pression of genes that control dendritic remodeling, result-
ing in the inhibition of synapse formation. Conversely, a
decrease in MEF2 activity increases spine density (Flavell et
al. 2006; Shalizi et al. 2006).
We previously showed that GR and MEF2 have several
target genes in common, including the c-JUN gene (Datson
et al. 2011a). c-JUN is a subunit of the transcription factor
AP-1 and is a ubiquitously expressed IEG with important
functions in cell death, differentiation, and inflammation
(Beck et al. 2009; Sun et al. 2005). The AP-1 family of
transcription factors is recruited in the activation of neuronal
circuits leading to long-term changes, such as long-term
memory formation (Alberini 2009). MEF2 is known to
induce transcription of c-JUN (Kato et al. 1997; Aude-
Garcia et al. 2010; Han and Prywes 1995), while GR
on the other hand is known to repress the expression of c-JUN
in vitro in AtT-20 cells and mouse fibroblast cells (Autelitano
1994; Wei et al. 1998). The aim of this study was to
investigate the molecular interplay of GR and MEF2 in a
neuronal context, using the shared target gene c-JUN as a
proof-of-principle.
Materials and Methods
Cell Culture and Treatment
Rat pheochromocytoma (PC-12) cells (passage # 15–29)
were cultured as described earlier (Morsink et al. 2006b).
In short, cells were grown in DMEM medium, supple-
mented with 0–10% fetal bovine serum and 0–10% horse
serum, dependent on the stage of neuronal differentiation.
For mRNA and protein analysis cells were seeded at a
confluency of 30–50% in pre-coated six-well plates
(356400, BD Biosciences, San Jose, CA, USA). For ChIP
experiments, the cells were seeded at 50% confluency in
pre-coated 175 cm2 plates (356478, BD Biosciences). Neu-
ronal differentiation was achieved by giving 50 ng/ml
Nerve Growth Factor Beta (NGF-ß) (N2513, Sigma-
Aldrich, St. Louis, MO, USA) every other day for 10 days.
Medium at day 9 of the differentiation was supplemented with
charcoal-stripped serum to deprive the medium of endoge-
nous steroids (Sarabdjitsingh et al. 2010b). At day 10, the cells
were treated for 30, 60, 90, or 180 min, dependent on the
experiment, with either vehicle (VEH) (0.1% ethanol) or
100 nM dexamethasone (DEX) (D1756, Sigma-Aldrich).
For GR blockade, cells were pretreated with VEH (0.1%
ethanol) or 1 mM RU486 (M8046, Sigma-Aldrich) for
60 min before addition of DEX or VEH.
Hippocampal Cultures
Newborn pups from NMRI mice were killed at postnatal
day 1. Brains were isolated and kept in Hank’s balanced salt
solution on ice until dissection. Hippocampi were dissected
in ice-cold dissection solution consisting of Krebs buffer
supplemented with 3 mg/ml BSA, 1.2 mM MgSO4, and
2 mM HEPES. Hippocampi (n012) were transferred to a
conical tube containing 1.5 ml of dissection solution sup-
plemented with 184 μg/ml trypsin. The tissue was incubated
at 37°C for 6 min. Subsequently, 3.5 ml of dissection solu-
tion supplemented with 0.65 mg/ml soyabean trypsin inhib-
itor; 10 μg/ml DNAse and 0.19 mM MgSO4 were added.
The trypsinated and DNase-treated hippocampi were centri-
fuged at 100×g for 3 min. The supernatant was discarded,
and the conical part of the tube was filled with 1.5 ml of
dissection solution supplemented with 5.2 mg/ml soyabean
trypsin inhibitor, 80 μg/ml DNAse, and 1.5 mM MgSO4.
The cells were dissociated by pipetting and left for 5 min at
room temperature (RT), allowing remaining tissue to settle.
The supernatant was transferred to a new tube containing
3.5 ml of dissection solution supplemented with 132 μM
CaCl2 and 120 μM MgSO4 and centrifuged for 10 min at
100×g. The cell pellet was resuspended in 3.5 ml ofMEM II+
B27 (MEM buffer supplemented with 0.5% D-glucose, 0.22%
bicarbonate, penicillin–streptomycin, 2 mM L-glutamate,
10% NU-serum, and 2% B27). After resuspension, the
concentrated cell solution was diluted to 7.5 ml MEM II+
B27. Cells were plated at a density of 50,000 live cells/well in
poly-D-lysine coated 96-well dishes. The yield from one pup
(two hippocampi) was approximately 400,000 living cells.
The day after plating, media was changed to MEM II+B27
buffer supplemented with 1 μM AraC (cytosine arabinoside).
The cells were left for 14 days in vitro before assaying.
Lentiviral shRNA Transduction, Stimulation, and RNA
Purification
High titer batches (>5×10−8 TU/ml) of lentiviral particles
harboring gene-specific short hairpin RNA (shRNA) target-
ing MEF2A (Sigma, TRCN0000095959) as well lentiviral
particles harboring control shRNA (Sigma, SHC002V) were
purchased from Sigma. The day after plating, hippocampal
cultures were transduced with lentiviral particles at the
following concentrations: 150,000 lentiviral particles/well,
75,000 lentiviral particles/well, and 37,500 lentiviral particles/
well. At day 14, the hippocampal cultures were stimulated for
90 min with 100 nM dexamethasone diluted in astrocyte-
conditioned media. The latter was to avoid glutamate-induced
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excitotoxicity by the media change. Subsequently, cells
were processed for RNA isolation using the Aurum Total
RNA 96 Kit (BioRad).
Real-Time Quantitative PCR
Total RNA was isolated using Trizol (15596, Invitrogen)
according to the manufacturer’s instructions. RNAwas diluted
to 50 ng/μl, and cDNA was synthesized using the iScript
cDNA synthesis kit (170–8897, Bio-Rad, Hercules, CA,
USA) according to the manufacturer’s protocol. Real-time
quantitative PCR (RT-qPCR) was performed on a Lightcycler
2.0 real-time PCR system (Roche Applied Science, Basel,
Switzerland) in combination with the Lightcycler FastStart
DNA MasterPLUS SYBR Green I Kit (03515885001, Roche).
As a control for genomic contamination, samples without
reverse transcriptase were used. The standard curve method
was used to quantify the expression differences (Livak and
Schmittgen 2001). Expression of TUBB2a (tubulin, beta 2a)
was used to normalize the RNA input.
RT-qPCR Primer Design
Primers were designed using primer-BLAST (NCBI,
Bethesda, USA). Apart from the built-in feature of selecting
primers that do not cross-hybridize, an additional check for
primer hairpins was performed using Oligo 7.0 (MBI Inc.
Cascade, USA). Primers were tested with RT-qPCR on a
standard curve to check the efficiency of the PCR reaction.
After a visual check for single melting peaks, the primer
products were put on a 2.0–2.5% agarose gel to check for
single products and absence of primer–dimers. The primer
sequences used are listed in Table S1.
Chromatin Immunoprecipitation
The exact procedure is described in Sarabdjitsingh et al.
(2010a). In short, cells were fixed with 1% formaldehyde
for 10 min at RT to crosslink DNA–protein interactions.
DNA was sonicated for 15–25 pulses to obtain DNA frag-
ments between 200 and 500 basepairs and checked visually
on a 1.2% agarose gel. Pre-cleared DNA (20–60 μg per
antibody) was incubated overnight (o/n) with 6 μg of either
anti-MEF2 (sc-313X; Santa Cruz), anti-GR (sc-8992X;
Santa Cruz) antibodies, or normal rabbit IgG (Santa Cruz;
sc-2027). The next day, 20 μl sepharose A beads were added
to the DNA–protein–antibody complexes. The samples
were washed 1× with low salt buffer (0.1% sodium dodecyl
sulfate (SDS); 2 mM ethylenediaminetetraacetic acid
(EDTA) pH 8.0; 20 mM Tris–HCl pH 8.0; 150 mM NaCl;
1% Triton-X-100), 1× with high salt buffer (as low salt
except 500 mM NaCl), 1× with LiCL buffer (0.25 M LiCl;
1 mM EDTA pH 8.0; 20 mM Tris–HCl pH 8.0; 1% NP-40;
1% NaDOC), and 2× with TE buffer (1 mM EDTA pH 8.0;
10 mM Tris–HCl pH 8.0). Subsequently, the DNA com-
plexes were eluted from the beads with 0.1 M NaHCO3 and
1% SDS, and the DNAwas reverse-crosslinked o/n at 4°C in
0.2 M NaCl. The samples were then treated for 1 h with
RNAse at 37°C and the DNA purified using Nucleospin
columns. The DNA was eluted in TE buffer for RT-qPCR
analysis. RT-qPCR on chromatin immunoprecipitation
(ChIP) material was performed directly on purified DNA.
ChIP results were obtained by performing three individual
ChIP replicates. IgG ChIP was used as a negative control for
aspecific precipitation while RT-qPCR of myoglobin was
used as a negative control for specific precipitation of DNA.
ChIP Primer Design
Primers were designed spanning a published MEF2 binding
site (MBS) upstream of the c-JUN transcription start site
(TSS) (Han and Prywes 1995; Haberland et al. 2007). GR
binding sites were identified in neuronally differentiated
PC-12 cells and rat hippocampus by GR ChIP-sequencing
(unpublished data). This resulted in identification of three GR
binding sites located ∼300 bp upstream and ∼2 and ∼8 kb
downstream the c-JUN TSS (Table 1). All three binding sites
were screened for putative glucocorticoid response element
(GRE) sequences using an in-house screening method to
identify evolutionary conserved GREs (Datson et al. 2011b).
Binding of MEF2 and GR to myoglobin was used as a
negative control as it is generally considered to be inaccessible
for transcription factor binding. Primer sequences used are
listed in Table S1.
Western Blotting
Protein was harvested in ice-cold RIPA buffer containing
protease inhibitors (#04693124001, Roche) and phospha-
tase inhibitors (NaVO3 and B-glycerophosphate). The cell
lysate was incubated on ice for 30 min, spun down, and the
supernatant transferred to a new tube. Protein concentration
was measured using the Pierce BCA Protein Assay kit
(23225, Thermo Scientific, Rockford, IL, USA) according
to the manufacturer’s protocol. Diluted samples were
supplemented with 1:2v/v of sample buffer (including
2.5% ß-mercaptoethanol and BromoPhenol Blue). Twen-
ty micrograms of each sample was loaded on 10%
polyacrylamide gel. After sufficient separation of the
proteins, they were transferred o/n at 4°C to a PVDF
(polyvinylidene fluoride) membrane. The membrane was
subsequently blocked in 5% low fat milk for 1 h at RT
for anti-α-tubulin or at or 4°C o/n for phospho-MEF2.
Primary antibodies were added in the blocking buffer
and incubated for 1 h at RT for anti-α-tubulin or 5 h at
4°C for phospho-MEF2 with either one of the following
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primary antibodies: anti-phospho S408 MEF2 rabbit mono-
clonal (ab51151, Abcam, Cambridge, UK), or anti-α-tubulin
DM1A mouse monoclonal antibody (T6199, Sigma). Blots
were incubated for 1 h at RT with the appropriate secondary
antibody: goat-anti rabbit IgG horseradish peroxidase (HRP)
secondary antibody (sc-2054, Santa Cruz) or goat-anti mouse
IgG HRP secondary antibody (sc-2055, Santa Cruz). Signals
were quantified using ImageJ (v1.42; National Institute of
Health, USA).α-Tubulin protein expression was used as input
normalization.
Statistics
Statistical analysis was performed with Sigmaplot 11.0 us-
ing independent t tests in the gene expression studies with/
without RU486 pre-treatment. A two-way ANOVA was
used with Tukey’s post hoc t tests.
Results
MEF2a Is Highly Expressed in PC-12 Cells
As a first step to study GR and MEF2 interaction, the
endogenous expression of MEF2 transcripts was determined
in neuronally differentiated PC-12 cells. MEF2a was most
abundantly expressed followed by MEF2d (Fig. 1). MEF2b
had a very low expression while MEF2c was not reliably
detected in PC-12 cells. Since MEF2a is most ubiquitous,
the following experiments focused on this gene.
GR Activation by DEX Downregulates c-JUN Expression
Previous studies showed that GR is highly expressed in
neuronally differentiated PC-12 cells (Morsink et al.
2006a). To study the GR regulation of c-JUN in a neuronal
context, neuronally differentiated PC-12 cells were treated
for several time-points with 100 nM of the synthetic gluco-
corticoid DEX. Expression of c-JUN mRNA was signifi-
cantly downregulated after 90 min DEX treatment (36% p<
0.001). After 180 min, c-JUN expression was significantly
higher compared with 90 min DEX (33% p<0.001) but still
significantly downregulated (16% p<0.01) compared with
the VEH control (Fig. 2a).
c-JUN Downregulation by DEX Is Mediated by GR
To check whether the DEX effect on c-JUN expression is
mediated via GR, PC-12 cells were pretreated with the GR
antagonist mifepristone (RU486). Since 90 min DEX treat-
ment showed the largest decrease in c-JUN mRNA expres-
sion, PC-12 cells were treated for this period with 100 nM
DEX, after being pretreated for 60 min with 1 mM RU486.
Again, DEX treatment resulted in a significant downregula-
tion (25% p<0.01) of c-JUN mRNA expression. However,
pretreatment with RU486, having no significant effect on its
own, completely prevented this effect, showing that the
DEX-induced downregulation is mediated via GR (Fig. 2b).
MEF2a Expression Is Not Changed by GR
Since c-JUN is also a known MEF2 target gene, we tested
whether DEX treatment changed the expression of MEF2a
Fig. 1 Relative expression levels of transcripts MEF2a, MEF2b, and
MEF2d in neuronally differentiated PC-12 cells under VEH conditions
(n06 per group). Expression is relative to MEF2a, which is set at
100%. Expression is normalized to TUBB2a (**p<0.01; ***p<0.001
sign. between transcripts)
Table 1 ChIP-seq results showing chromosomal locations of the three peaks where increased GR binding was found
Binding site Chr Peak start Peak end Distance from TSS GRE sequence Origin
GBS 1 5 115361507 115361560 −275 None Hippocampus
GBS 2 5 115359115 115359210 2,097 GAACGGGCTGTGCC Hippocampus
GBS 3 5 115353332 115353445 7,871 GAACCAAATGTTCA PC-12 cells
The three sites are designated GBS 1, GBS 2, and GBS 3. ‘Origin’ refers to the ChIP-sequencing experiment in which the GBS was first observed.
Distance from TSS refers to the distance between the center of the peak and the transcription start site of c-JUN. A negative value indicates
upstream the TSS. The MEF2 binding site (MBS 1) was previously identified (Han and Prywes 1995)
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in PC-12 cells. MEF2a expression showed no change fol-
lowing DEX treatment at the time points studied (Fig. 3a).
MEF2a Is Necessary for the GR-Mediated Effect on c-JUN
To examine whether MEF2a is necessary for the DEX effect
on c-JUN expression, we aimed to knock down MEF2a in
PC-12 cells before treatment with DEX. Although MEF2a
could be knocked down in non-differentiated PC-12 cells, it
failed when cells have a neuronal phenotype (data not
shown). Since MEF2 proteins are involved in regulation of
the neuronal phenotype (Shalizi et al. 2006; Lin et al. 1996;
Tian et al. 2010), as well as in neuronal viability (McKinsey
et al. 2002), we did not consider knocking down of MEF2a
before differentiation to be a good alternative. Instead, the
involvement of MEF2a in DEX-mediated effects on c-JUN
gene expression was evaluated in primary hippocampal
cultures using lentiviral shRNA-mediated MEF2a knock-
down. Hippocampal cultures were transduced and incubated
with lentiviral particles harboring either negative control
shRNA (scrambled sequence) or a gene-specific shRNA
targeting MEF2a followed by a 90 min 100 nM DEX
treatment. Gene expression measurements revealed a signif-
icant knockdown of MEF2a (78% p<0.001) in VEH-treated
cells compared with cells transduced with negative control
shRNA (Fig. 3b). DEX treatment did not influence MEF2a
expression, neither in the control condition nor in MEF2a
shRNA transduced cells. c-JUN expression showed a sig-
nificant downregulation after DEX in control cells (44% p<
0.01) (Fig. 3c), in accordance with our findings in PC-12
cells (Fig 2b). Knockdown of MEF2a, however, resulted in
a downregulation of c-JUN comparable to the effect of DEX
in control cells (38% p<0.001). Surprisingly, DEX treat-
ment on top of knocked down MEF2a did not result in any
additional knockdown.
MEF2a Phosphorylation Is Increased by GR
Many studies have shown the importance of phosphoryla-
tion of serine 408 in MEF2a for the activity of MEF2
(Shalizi et al. 2006; Gregoire et al. 2006; Li et al. 2001).
An increased ratio of phosphorylated versus dephosphory-
lated MEF2a has been shown to decrease MEF2 transcrip-
tional activity. Therefore, we measured this important
hallmark after 60 min of 100 nM DEX treatment (Fig. 4a, b)
in neuronally differentiated PC-12 cells. DEX treatment in-
duced a marked increase in phosphorylation of MEF2a com-
pared with VEH-treated cells (125% p<0.05). An
independent experiment showed comparable changes in phos-
phorylation while, at 180 min, no difference in phosphoryla-
tion was detected anymore (results not shown).
GR- and MEF2-DNA Binding Are Increased Around
the c-JUN Gene
MEF2 and GR are well-known transcription factors and
exert their action by binding directly or indirectly to the
DNA. First, we investigated whether GR activation changed
the binding of MEF2 to a previously described MEF2 bind-
ing site (MBS) upstream of c-JUN (Han et al. 1992) using
ChIP. In addition, we identified three novel GR binding sites
(GBS) based on ChIP-Seq data for GR in PC-12 cells as
well as rat hippocampus (unpublished data): a GBS 300 bp
upstream to c-JUN (GBS1) and located within a short distance
(< 100 bp) from the MBS and another two GBS ∼2 and ∼8 kb
Fig. 2 a c-JUN mRNA expression at 30, 90, or 180 min of DEX
treatment (n06 per group). For each time point, expression level is
relative to its VEH counterpart which is set at 100% and indicated by
the dashed line. Expression is normalized to TUBB2a (**p<0.01;
***p<0.001 sign. vs corresponding VEH treatment) (###p<0.001
sign. between time points) b c-JUN mRNA expression at 90 min of
DEX treatment with and without 60 min RU486 pretreatment (n06 per
group). Expression level is relative to VEH treated cells without
pretreatment, set at 100%. Expression is normalized to TUBB2a (*p<
0.05; **p<0.01 sign. vs VEH treatment) (##p<0.01 sign. vs DEX
without pre-treatment)
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Fig. 3 a MEF2a mRNA
expression in neuronal PC-12
cells at 30, 90, or 180 min of
DEX treatment (n06 per
group). For each time point,
expression level is relative to its
VEH counterpart which is set at
100% and indicated by the
dashed line. Expression is
normalized to TUBB2a. b
MEF2a mRNA expression at
90 min of DEX treatment in
lentiviral transduced primary
hippocampal neurons express-
ing either scrambled shRNA or
MEF2a shRNA (n03 per
group). Expression level is rel-
ative to scrambled shRNA
transduced and VEH treated
cells, set at 100%. Expression is
normalized to TUBB2a
(##p<0.01 sign. vs scrambled
shRNA) c c-JUN mRNA
expression at 90 min of DEX
treatment in lentiviral trans-
duced primary hippocampal
neurons expressing either
scrambled shRNA or MEF2a
shRNA (n03 per group).
Expression level is relative to
scrambled shRNA transduced
and VEH-treated cells, set at
100%. Expression is normal-
ized to TUBB2a (**p<0.01
sign. vs VEH treatment)
(##p<0.01 sign. vs scrambled
shRNA)
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downstream of the c-JUN TSS (GBS2 and GBS3, re-
spectively) (Table 1 and Fig. 5a). We investigated
whether activated GR showed binding to these sites.
To this end, neuronally differentiated PC-12 cells were
treated for 60 min with 100 nM DEX, and DNA–protein
complexes were immunoprecipitated using GR or MEF2 anti-
bodies. MEF2 binding to the upstream MBS was increased
after 60 min DEX treatment (2.26-fold p<0.01) (Fig. 5b).
Moreover, DEX treatment increased GR binding to both
GBS1 and GBS3 (p<0.05 for both GBS1 and GBS3) but
not to GBS2 (Fig. 5b). Binding of GR and MEF2 to a control
region (myoglobin) was not enhanced after DEX treatment
(results not shown). Screening of the GBS for putative GREs
revealed presence of a GRE at the downstreamGBS 3, but not
in GBS1.
Discussion
GR and MEF2 are both transcription factors known to
influence neuronal plasticity. We previously observed that
GR and MEF2 have several target genes in common, in-
cluding c-JUN, and hypothesized that both transcription
factors may cooperate in a neuronal context in the regulation
of genes important for plasticity. Here, we present evidence
that there is an interplay of GR and MEF2 in the regulation
of c-JUN at multiple levels. Our results show that activation
of GR regulates phosphorylation and hence, transcriptional
activity of MEF2a as well as MEF2a-DNA binding upstream
of target gene c-JUN.
In Vitro Model
To study GR and MEF2 effects on target gene c-JUN, we
used neuronally differentiated PC-12 cells, a frequently used
neuronal cell model. Previous studies showed that both GR
and MEF2d are highly expressed in this cell line (Morsink et
al. 2006a; Kim et al. 2011). Here we show here that the
MEF2a isoform, which is highly expressed in the limbic
system, has even higher expression levels than MEF2d.
Therefore, we considered neuronal PC-12 cells to be a good
model system to study the interaction of MEF2 and GR
signaling in a neuronal context. Since lentiviral- or siRNA-
Fig. 4 MEF2a S408 phosphorylation level after 60 min of DEX
treatment (n03 per group). a Phosphorylation level is relative to
60 min VEH treatment, set at 100%. Expression is normalized to
alpha-tubulin (*p<0.05 sign. vs VEH treatment). b Representative
example of protein expression
Fig. 5 Binding levels of GR and MEF2a in the vicinity of the c-JUN
gene (n03 per group). a Schematic overview of the c-JUN gene and
surrounding sites. GR binding sites 1, 2, and 3 are depicted in grey and
the MBS1 is depicted in black. Numbers inside the boxes indicate
distance from the beginning and end of the peak to the TSS. b ChIP
results representing DNA-binding of GR at three distinct binding sites
designated GBS1, GBS2, and GBS3, and DNA-binding of MEF2a at
the MEF2-binding site designated MBS1. Results are immunoprecipi-
tated fractions plotted as percentage of total input DNA. The immuno-
precipitated fraction is normalized to IgG binding (*p<0.05, **p<0.01
sign. vs VEH treatment)
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mediated knockdown of MEF2a proved to be difficult in
this cell line after differentiation to a neuronal phenotype,
we decided to use primary hippocampal neurons to study the
effect of MEF2a knockdown on c-JUN expression. Note
that DEX downregulates c-JUN to the same extent in both
cell lines.
c-JUN mRNA Regulation as Proof-of-Principle for MEF2
and GR Interplay
To study the effect of GR on MEF2 activity and DNA-
binding, we focused on the AP-1 transcription factor subunit
c-JUN for several reasons. AP-1 is a ubiquitously expressed
transcription factor and an important mediator of activity-
induced dendritic growth (Hartwig et al. 2008). MEF2 is
also a mediator of dendritic growth (possibly via c-JUN) and
enhances the expression of c-JUN in an activity-dependent
manner (Flavell et al. 2008). Indeed, we show that acute
activation of GR by DEX downregulates the expression of
c-JUN, which is possibly mediated by decreased transcrip-
tional activity of MEF2a due to phosphorylation.
MEF2a Is Necessary for the GR-Mediated Effect on c-JUN
Transcription
Knockdown of MEF2a led to a decrease in expression of c-
JUN, implying that expression of c-JUN is mediated by
MEF2a under vehicle conditions. This idea is strengthened
by our ChIP results which indicate that MEF2 is already
bound to the MBS under VEH conditions. Other transcription
factors than MEF2a likely also play a role, since the down-
regulation of c-JUN was relatively small compared with the
knockdown of MEF2a. Indeed, MEF2d and MEF2c are also
able to regulate c-JUN expression and are therefore possible
candidates controlling c-JUN expression. Interestingly, DEX
treatment on top of MEF2a knockdown had no additional
effect whatsoever, suggesting that the GR cannot exert its
effect after knockdown of (phosphorylated) MEF2a.
Transcriptional Machinery Is Repressed by Phosphorylated
and DNA-Bound MEF2a
Several studies have shown that post-translational modifi-
cation of MEF2 significantly alters its activity (Molkentin et
al. 1996; Shalizi et al. 2006; Gregoire et al. 2006). Phos-
phorylation of serine 408 in MEF2a has an inhibitory effect
on MEF2 transcriptional activity (Flavell et al. 2006; Gong
et al. 2003; Shalizi et al. 2006; Potthoff and Olson 2007).
Conversely, dephosphorylation of serine 408 in MEF2a is
induced by neuronal activity, leading to activation of calci-
neurin, a potent phosphatase of MEF2 (Flavell et al. 2006;
Shalizi et al. 2006). We show here for the first time that
DEX treatment increases phosphorylation of MEF2a.
The DEX effect on phosphorylation and hence decreased
activity of MEF2a and increased DNA binding at the same
time, described in this study, seem contradictory at first.
However, results on phospoinositide-3-kinase, catalytic,
gamma polypeptide (PIK3CG) binding and expression re-
veal a similar response pattern. Pulipparacharuvil et al.
showed that increased phosphorylation of MEF2a at S408
correlated with increased binding of MEF2 close to the TSS
of PIK3CG and decreased expression of the transcript
(Pulipparacharuvil et al. 2008). In agreement with this,
McKinsey et al. showed that activated MEF2 is able to
recruit histone acetyl transferases (HATs) such as p300,
while phosphorylated MEF2 recruits histone deacetylases
(HDACs) such as HDAC 4, 5, 7, and 9. MEF2 thus operates
as a switch and is therefore able to directly activate or
repress the transcriptional machinery (McKinsey et al.
2002).
A similar mechanism may be involved in regulation of c-
JUN (Fig. 6). At 60 min of DEX treatment, MEF2a is
phosphorylated and bound to the DNA to a higher extent
than under VEH conditions. This may imply that the tran-
scriptional machinery is repressed, probably by attracting
HDACs. At the same time, DNA binding of GR to GBS1, in
the vicinity of MEF2a, is also increased, likely due to
indirect binding via an intermediate transcription factor,
since this site was not shown to contain a putative GRE. It
was recently shown that increased HDAC7-DNA binding
within exactly the same region as the GBS1 results in c-JUN
downregulation in a deacetylase-independent manner (Ma
and D’Mello 2011), suggesting that HDAC attraction may
repress the transcriptional machinery without preventing
other transcription factors to bind to the DNA.
GC effects on the transcriptional machinery may repre-
sent a more general phenomenon underlying some of the
long-term changes in neuronal expression that have been
observed in response to acute GR activation. For example,
in the CA1 area of the hippocampus, long-term potentiation
was found to be enhanced up to 24 h after a brief stress-
Fig. 6 Schematic overview of the obtained results. Activation of GR
by agonist DEX activates the kinase CDK5, responsible for phosphor-
ylation of its target proteins, including GR and MEF2. MEF2, now
phosphorylated, is increasingly bound to the DNA where it is sug-
gested to act as a transcriptional repressor. GR is also bound to the
DNA under this condition. However, to what extent GR itself is
responsible for c-JUN downregulation remains to be studied
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induced rise in corticosterone, accompanied by an enhanced
expression of GR that was still present 24 h after termination
of the stress response (Ahmed et al. 2006). Another study,
focusing directly on the plasticity-related gene neuropsin,
found that corticosterone readily upregulates this gene in the
hippocampus, which remains elevated for over 24 h (Harada
et al. 2008). Even weeks after stress, a persistent overex-
pression of the stress-associated splice variant of the neuro-
nal acetylcholinesterase gene was observed, likely caused
by long-term expression of the SC35 splicing factor in
response to stress (Meshorer et al. 2005).
Exactly how activated GR leads to increased phosphoryla-
tion of MEF2a is not known. The mainly neuron-specific
kinase CDK5 phosphorylates MEF2a at serine 408 (Gong et
al. 2003). Since GR is known to recruit CDK5 for its own
phosphorylation upon DEX binding (Kino et al. 2007), we
hypothesize that MEF2a is recruited at the same time by
GR and hence is phosphorylated by CDK5. Alternatively,
CDK5 activity may be enhanced upon binding to GR and
subsequently, after detaching fromGR, starts to phosphorylate
other target proteins like MEF2a. Furthermore, it has been
shown that calcineurin (CaN) mRNA expression, a phospha-
tase responsible for reducing phosphorylation at serine 408 in
MEF2a, is significantly reduced by corticosterone treatment
(Morsink et al. 2006b), which might also lead to increased
phosphorylation levels. However, downregulation of CaN
was only observed at 180 min of corticosterone treatment,
while the present study indicates a phosphorylation difference
already at 60 min of DEX treatment.
Another possibility of decreased transcriptional activity by
MEF2might be the downregulation of transcriptional enhancers
like the previously mentioned p300. This HAT is a direct target
of microRNA-132 which was found to be extensively upregu-
lated under stressful conditions (Shaltiel et al. 2012). MEF2
plays an important role in neuronal differentiation (Shalizi and
Bonni 2005). Since miR-132 was also recently found to play an
important role in neuronal differentiation of PC-12 cells as well
as of hippocampal neurons, it is possible that elevated cortico-
sterone levels influence MEF2 function via this pathway as
well (Luikart et al. 2011; Magill et al. 2010).
Conclusion
This study provides new insights into the molecular inter-
play at multiple levels of two transcription factors that are
central to neuronal plasticity, GR and MEF2a. To our
knowledge, this is the first report showing a direct effect
of GR on the activity and DNA-binding of MEF2a. An
interesting avenue for future studies will be to determine
how stress and subsequent glucocorticoid release influences
MEF2 in several brain areas and how this might affect
plasticity-based processes such as learning and memory.
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